GASTON-DREYFUS REMI purchased 9.7% of their position (106.36K shares) of BIONIK LABORATORIES CORP. on the open market
Open‑market purchase worth $399.9K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/28/2019ACC: 0001144204-19-042003
Director10% Owner
Since Jul 2018
+106.36K
Net shares
Net buyer
$399.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
106.36K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+106.36K
Price / share
$3.76
Trade value
$399.91K
% of position
9.7%
8/26/2019
1.10M→1.20M
Total
Net shares
+106.36K
Net value
$399.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/26/2019 | P · Purchase | +106.36K | $3.76 | $399.91K | 9.7% | 1.10M | 1.20M |
| Total | +106.36K | $399.91K | ||||||
Derivative Transactions0
No derivative transactions reported